Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Companion diagnostics for precision medicine

23 March 2023 09:30-17:00, London, United Kingdom


Introduction
Companion diagnostics are becoming more and more important with time together with the growth of targeted therapies. Precision medicine approach aims to stratify patients with the ultimate aim of targeting patients who are most likely to respond to a specific treatment. Currently, CDx are used for many diseases lung cancer, colorectal cancer, breast cancer and melanoma.

At the Å·ÃÀAV, delegates will be able to explore the current state of the art in vitro diagnostic tests used by the industry and explore the different scientific measurements that are needed to develop and deliver a CDx into the market.

CDx is a platform technology and can be used for many other diseases, join us and lets discuss the future of healthcare and personalised treatment.

Useful links

Speakers
  • Prof Lorna Harries University of Exeter / SENISCA, United Kingdom
  • Dr Dahlia Salman Bioxhale ltd, United Kingdom
  • Dr Elizabeth Young NHS, United Kingdom

Venue
The Å·ÃÀAV

The Å·ÃÀAV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Committee
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*